WebDisclosure WebDisclosure
Basculer en Français
10818 Companies
234548 Keywords
163383 Articles
125493 Press releases
Headlines Articles Press releases Rabalon Remove
  1. Home
  2. Companies
  3. Rabalon
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/10/2024 at 18:50, 2 years 3 months ago

    ITCON Azerbaijan 2024: A Collaborative Success by ManageEngine and Rabalon

    Cybersecurity Business Continuity ITCON 2024 ManageEngine Rabalon
  • BRIEF

    published on 05/10/2024 at 18:50, 2 years 3 months ago

    ITCON Azerbaïdjan 2024 : un succès collaboratif de ManageEngine et Rabalon

    La Cyber-sécurité Continuité De L'activité Rabalon ITCON2024 Gérer Le Moteur
  • PRESS RELEASE

    published on 05/10/2024 at 18:45, 2 years 3 months ago

    ManageEngine, in Collaboration With Rabalon, Hosts ITCON Azerbaijan 2024

    The second edition of ITCON Azerbaijan, led by ManageEngine and Rabalon, gathered 200+ IT professionals showcasing cutting-edge IT solutions at Hilton Hotel in Baku on May 7, 2024
    Cybersecurity ManageEngine Rabalon ITCON Azerbaijan IT Professionals
    Logo of Rabalon
Accesswire
  • Published on 08/11/2026 at 13:30, 2 minutes ago

    Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market

  • Published on 08/11/2026 at 13:00, 32 minutes ago

    AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification

  • Published on 08/11/2026 at 12:10, 1 hour 22 minutes ago

    CoTec Holdings Corp. Announces $20m Private Placement Of Unsecured Convertible Debentures

  • Published on 08/11/2026 at 12:00, 1 hour 32 minutes ago

    Bitterroot Resources Ltd. - Update on the LM Nickel-Copper Project, Michigan, USA

  • Published on 08/11/2026 at 12:00, 1 hour 32 minutes ago

    Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation

View all ACCESSWIRE
EQS Group
  • Published on 08/11/2026 at 13:05, 27 minutes ago

    Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia

  • Published on 08/11/2026 at 13:00, 32 minutes ago

    Original-Research: Aspermont Ltd. (von GBC AG): Buy

  • Published on 08/11/2026 at 12:40, 52 minutes ago

    Green Street Launches Its MCP Server, Powered by GreenStreetAI™, Connecting CRE Intelligence Directly to Corporate Instances of Claude, ChatGPT, Gemini, and Other AI Platforms

  • Published on 08/11/2026 at 12:30, 1 hour 2 minutes ago

    Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  • Published on 08/11/2026 at 12:05, 1 hour 27 minutes ago

    Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 19 hours 32 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 18:00, 19 hours 32 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

  • Published on 08/10/2026 at 17:45, 19 hours 47 minutes ago

    Weekly share buyback

  • Published on 08/10/2026 at 17:45, 19 hours 47 minutes ago

    Déclaration hebdomadaire de rachat d'actions

  • Published on 08/10/2026 at 11:53, 1 day 1 hour ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy